T 1243/12 (Treatment of autoimmune diseases/GENENTECH) of 18.06.2015
- European Case Law Identifier
- ECLI:EP:BA:2015:T124312.20150618
- Date of decision
- 18 June 2015
- Case number
- T 1243/12
- Online on
- 18 March 2016
- Petition for review of
- -
- Application number
- 00928991.9
- IPC class
- A61K 39/395
- Language of proceedings
- English
- Distribution
- No distribution (D)
- Download
- Decision in English
- OJ versions
- No OJ links found
- Other decisions for this case
- -
- Abstracts for this decision
- -
- Application title
- Treatment of autoimmune diseases with antagonists which bind to B-cell surface markers
- Applicant name
- Genentech, Inc.
Biogen Inc. - Opponent name
- 01: Emergent Product Development Seattle LLC
02: MEDIMMUNE, INC.
03: Elend, Almut Susanne
04: CENTOCOR, INC.
05: GLAXO GROUP LIMITED
06: Merck Serono SA
07: Genmab A/S
08: Wyeth LLC - Board
- 3.3.04
- Headnote
- -
- Relevant legal provisions
- European Patent Convention Art 56
- Keywords
- Inventive step - (no)
- Catchword
- -
- Cited cases
- -
- Citing cases
- -
Order
For these reasons it is decided that:
The appeal is dismissed